Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Savannah, GA
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Bellevue, NE
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Bellevue, NE
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Warwick, RI
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Rock Hill, SC
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Arlington, TX
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Arlington, TX
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Austin, TX
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Sugarland, TX
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Sugarland, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  11/23/2015
mi
from
Buenos Aires,
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 11/23/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
Phase 1 Single Center, Randomized, Controlled Study Using Sublingual Immunotherapy for Timothy Grass and Dust Mite Allergies
Status: Enrolling
Updated:  11/24/2015
Stanford University
mi
from
Stanford, CA
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
Phase 1 Single Center, Randomized, Controlled Study Using Sublingual Immunotherapy for Timothy Grass and Dust Mite Allergies
Status: Enrolling
Updated: 11/24/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
St Louis, MO
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
St Louis, MO
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Papillion, NE
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Papillion, NE
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
El Paso, TX
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Denver, CO
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Riverside, CA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
San Antonio, TX
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Upland, PA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Upland, PA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Princeton, NJ
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Princeton, NJ
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Mission Viejo, CA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Rolling Hills Estates, CA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Rochester, NY
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Louisville, KY
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Minneapolis, MN
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Los Angeles, CA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Spartanburg, SC
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Los Angeles, CA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Dallas, TX
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Denver, CO
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
River Forest, IL
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
River Forest, IL
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Baltimore, MD
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Los Angeles, CA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Owensboro, KY
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Lake Oswego, OR
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Colorado Springs, CO
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Tacoma, WA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Medford, OR
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated:  11/27/2015
Clinical Research Facility
mi
from
Richmond, VA
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Status: Enrolling
Updated: 11/27/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials